あすか製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4886/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/09/02 | 日証協 | 158,141株 | -20.48% | 15,917株 | -83.32% | 220,955株 | -4.56% | 17,286株 | -1.14% |
2022/08/26 | 日証協 | 198,858株 | +22.49% | 95,417株 | +17.93% | 231,502株 | +5.23% | 17,486株 | -66.19% |
2022/08/19 | 日証協 | 162,341株 | +6.56% | 80,908株 | +65.85% | 219,991株 | +6.71% | 51,713株 | -24.79% |
2022/08/12 | 日証協 | 152,341株 | -12.92% | 48,783株 | +81.53% | 206,167株 | -4.54% | 68,758株 | +164.5% |
2022/08/05 | 日証協 | 174,941株 | -2.38% | 26,873株 | -2.28% | 215,976株 | -9.07% | 25,995株 | -17.88% |
2022/07/29 | 日証協 | 179,214株 | +12.42% | 27,500株 | +91.5% | 237,512株 | +10.54% | 31,654株 | -2.56% |
2022/07/22 | 日証協 | 159,417株 | -10.36% | 14,360株 | -50.82% | 214,863株 | -9.02% | 32,487株 | -47.7% |
2022/07/15 | 日証協 | 177,833株 | -9.51% | 29,200株 | -9.03% | 236,177株 | -4.42% | 62,111株 | +30.47% |
2022/07/08 | 日証協 | 196,532株 | -2.67% | 32,100株 | -66.53% | 247,104株 | +1.31% | 47,605株 | -57.65% |
2022/07/01 | 日証協 | 201,932株 | +10.51% | 95,900株 | +74.33% | 243,897株 | +0.91% | 112,410株 | +94.23% |
2022/06/24 | 日証協 | 182,732株 | +25.05% | 55,012株 | +185.35% | 241,694株 | +13.88% | 57,876株 | +23.37% |
2022/06/17 | 日証協 | 146,132株 | +4.72% | 19,279株 | +431.98% | 212,231株 | -0.09% | 46,914株 | +21.14% |
2022/06/10 | 日証協 | 139,541株 | +0.14% | 3,624株 | -93.64% | 212,431株 | +0.66% | 38,726株 | -11.17% |
2022/06/03 | 日証協 | 139,341株 | -8.73% | 57,000株 | +42.14% | 211,031株 | -1.31% | 43,597株 | -58.96% |
2022/05/27 | 日証協 | 152,661株 | -11.33% | 40,100株 | +78.22% | 213,831株 | +1.18% | 106,226株 | +104.51% |
2022/05/20 | 日証協 | 172,161株 | +7.27% | 22,500株 | +127.99% | 211,331株 | +5.34% | 51,941株 | +9.75% |
2022/05/13 | 日証協 | 160,492株 | -1.41% | 9,869株 | +3.88% | 200,616株 | -1.62% | 47,326株 | +484.27% |
2022/05/06 | 日証協 | 162,792株 | -6.49% | 9,500株 | +352.38% | 203,917株 | -5.92% | 8,100株 | -71.46% |
2022/04/28 | 日証協 | 174,092株 | +1.87% | 2,100株 | -91.6% | 216,750株 | +1.98% | 28,380株 | -52.4% |
※株式分割は考慮していませんのでご注意ください。
Page Top